Dr. Bing Wang, Associate Professor, is currently the Director of the Molecular Therapy Laboratory and faculty member at Center for Cellular and Molecular Engineering in the Department of Orthopaedic Surgery at the University of Pittsburgh, School of Medicine. Additionally, he presently holds secondary appointments as an Associate Professor in the Department of Neurology and also in the McGowan Institute for Regenerative Medicine.
Dr. Wang received his MD from Tong-Ji Medical School, Huazhong University of Science and Technology. After receiving his medical degree, he studied at the Institute of Microbiology, Chinese Academy of Sciences in Beijing, where he earned his PhD in Molecular Biology and Virology. Dr. Wang then held a position as an Associate Professor at the Chinese Academy of Sciences in China while simultaneously working as a post-doctoral fellow at the University of Science and Technology in Hong Kong. He also spent time as the Physician-in-Charge at the Institute of Geriatrics, Tong-Ji Medical School.
When Dr. Wang joined the University of Pittsburgh in 1999, he was a Research Associate in the Department of Molecular Genetics and Biochemistry and was subsequently promoted to an Assistant Professor in the Department of Orthopaedic Surgery and Neurology. Shortly before becoming a faculty member at the University of Pittsburgh, Dr. Wang was awarded two, 2-year postdoctoral scholarships. He also won the Orthopaedic Research Society’s New Investigator Recognition Award in both 2007 and 2011, and also won the North American Spine Society and the Spine Journal’s 2011 Outstanding Paper Award.
Dr. Wang has been engaging in recombinant adeno-associated viral (rAAV) vector-mediated gene transfer and associated techniques for the treatment of musculoskeletal diseases such as DMD for many years. He has laid the groundwork for researchers by developing gene and cell-based molecular techniques for in vivo and ex vivo gene transfer, as well as biomaterial-mediated gene transfer for the treatment of musculoskeletal diseases, including the repair and regeneration of muscle, bone, ligament, tendon, and joint capsules. Since 1998, he has authored/co-authored 33 peer-reviewed publications, 2 review papers, 3 book chapters, and has published 82 abstracts in national/international conferences. Dr. Wang also participates on the Editorials Boards of several professional journals. Dr. Wang was elected to the Nominating Committee of the Orthopaedic Research Society for the 2013-2014 term. He also continues to serve as a committee member of the American Society of Gene and Cell Therapy, and the Musculoskeletal Disorders Gene & Cell Therapy Committee, for another term, 2013 to 2016.